97 related articles for article (PubMed ID: 37055432)
1. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.
Hu Y; Qi C; Shi J; Tan W; Adiljan Abdurusul ; Zhao Z; Xu Y; Wu H; Zhang Z
Cell Mol Life Sci; 2023 Mar; 80(4):106. PubMed ID: 36952018
[TBL] [Abstract][Full Text] [Related]
2. C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy.
Zhang Q; Bin S; Budge K; Petrosyan A; Villani V; Aguiari P; Vink C; Wetzels J; Soloyan H; La Manna G; Podestà MA; Molinari P; Sedrakyan S; Lemley KV; De Filippo RE; Perin L; Cravedi P; Da Sacco S
JCI Insight; 2024 Jan; 9(4):. PubMed ID: 38227377
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1.
Das C; Hoang QQ; Kreinbring CA; Luchansky SJ; Meray RK; Ray SS; Lansbury PT; Ringe D; Petsko GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4675-80. PubMed ID: 16537382
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-Terminal Hydrolase L5 Plays an Essential Role in the Fly Innate Immune Defense against Bacterial Infection.
Zhang C; Zhang S; Kong F; Xiao Y; She K; Jin Y; Li J; Qadeer A; Zheng X; Ji S; Hua Y
Front Biosci (Landmark Ed); 2023 Nov; 28(11):294. PubMed ID: 38062818
[TBL] [Abstract][Full Text] [Related]
5. Erratum. β-Cell Dysfunctional ERAD/Ubiquitin/Proteasome System in Type 2 Diabetes Mediated by Islet Amyloid Polypeptide-Induced UCH-L1 Deficiency. Diabetes 2011;60:227-238.
Costes S; Huang CJ; Gurlo T; Daval M; Matveyenko AV; Rizza RA; Butler AE; Butler PC
Diabetes; 2023 Dec; 72(12):1881. PubMed ID: 37683136
[No Abstract] [Full Text] [Related]
6. Publisher Correction: Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis.
Reichelt J; Sachs W; Frömbling S; Fehlert J; Studencka-Turski M; Betz A; Loreth D; Blume L; Witt S; Pohl S; Brand J; Czesla M; Knop J; Florea BI; Zielinski S; Sachs M; Hoxha E; Hermans-Borgmeyer I; Zahner G; Wiech T; Krüger E; Meyer-Schwesinger C
Nat Commun; 2023 Apr; 14(1):2453. PubMed ID: 37117182
[No Abstract] [Full Text] [Related]
7. ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1/IRF1 axis in diabetic kidney disease.
Ito M; Ducasa GM; Molina JD; Santos JV; Mallela SK; Kim JJ; Ge M; Mitrofanova A; Sloan A; Merscher S; Mimura I; Fornoni A
Sci Rep; 2023 Jun; 13(1):9616. PubMed ID: 37316538
[TBL] [Abstract][Full Text] [Related]
8. The proteasome modulates endocytosis specifically in glomerular cells to promote kidney filtration.
Sachs W; Blume L; Loreth D; Schebsdat L; Hatje F; Koehler S; Wedekind U; Sachs M; Zieliniski S; Brand J; Conze C; Florea BI; Heppner F; Krüger E; Rinschen MM; Kretz O; Thünauer R; Meyer-Schwesinger C
Nat Commun; 2024 Mar; 15(1):1897. PubMed ID: 38429282
[TBL] [Abstract][Full Text] [Related]
9. Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy.
Sun M; Shi G; Zhang X; Kan C; Xie S; Peng W; Liu W; Wang P; Zhang R
Aging (Albany NY); 2024 Jan; 16(1):964-982. PubMed ID: 38175721
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional UCH-L1 inhibits proteostasis.
Wang M
Nat Rev Nephrol; 2023 Jul; 19(7):424. PubMed ID: 37258710
[No Abstract] [Full Text] [Related]
11. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
[TBL] [Abstract][Full Text] [Related]
12. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
Cui JH; Xie X
Inflammation; 2017 Apr; 40(2):657-665. PubMed ID: 28116572
[TBL] [Abstract][Full Text] [Related]
13. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
Gong B; Leznik E
Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
[TBL] [Abstract][Full Text] [Related]
14. Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis.
Reichelt J; Sachs W; Frömbling S; Fehlert J; Studencka-Turski M; Betz A; Loreth D; Blume L; Witt S; Pohl S; Brand J; Czesla M; Knop J; Florea BI; Zielinski S; Sachs M; Hoxha E; Hermans-Borgmeyer I; Zahner G; Wiech T; Krüger E; Meyer-Schwesinger C
Nat Commun; 2023 Apr; 14(1):2114. PubMed ID: 37055432
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
